Journal
JOURNAL OF HUMAN GENETICS
Volume 56, Issue 4, Pages 270-276Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/jhg.2011.1
Keywords
apoptosis; cisplatin resistance; esophageal carcinoma; microRNA; YAP1
Categories
Funding
- Ministry of Education, Culture, Sports, Science and Technology
- New Energy and Industrial Technology Development Organization
Ask authors/readers for more resources
MicroRNAs (miRNAs) are endogenous non-coding RNAs that function as negative regulators of gene expression. Alterations in miRNA expression have been shown to affect tumor growth and response to chemotherapy. In this study, we explored the possible role of miRNAs in cisplatin resistance in esophageal squamous cell carcinoma (ESCC). First we assessed the sensitivity of nine human ESCC cell lines (KYSE series) to cisplatin using an in vitro cell viability assay, and then we compared the miRNA profiles of the cisplatin-sensitive and -resistant cell lines by miRNA microarray analysis. The two groups showed markedly different miRNA expression profiles, and 10 miRNAs were found to be regulated differentially between the two groups. When miR-141, which was the most highly expressed miRNA in the cisplatin-resistant cell lines, was expressed ectopically in the cisplatin-sensitive cell lines, cell viability after cisplatin treatment was increased significantly. Furthermore, we found that miR-141 directly targeted the 3'-untranslated region of YAP1, which is known to have a crucial role in apoptosis induced by DNA-damaging agents, and thus downregulated YAP1 expression. Our study highlights an important regulatory role for miR-141 in the development of cisplatin resistance in ESCC. Journal of Human Genetics (2011) 56, 270-276; doi:10.1038/jhg.2011.1; published online 3 February 2011
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available